Cibles et Médicaments des Infections et de l'Immunité
- Research works
- 68 ▼ 23% vs 2013–17
- Citations
- 1.1k 16.0 per fractional work
- Top-10% rate
- 25.6% record average 16.5%
- Open access
- 46% world 28%
Not ranked overall: Cibles et Médicaments des Infections et de l'Immunité is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 15.7×. Every wedge is a field page.
- Veterinary 15.7×
- Immunology and Microbiology 6.0×
- Biochemistry, Genetics and Molecular Biology 4.3×
- Pharmacology, Toxicology and Pharmaceutics 3.6×
- Chemistry 3.0×
- Medicine 2.3×
- Agricultural and Biological Sciences 2.1×
- Health Professions 1.5×
- Neuroscience 1.0×
- Dentistry 0.8×
- Nursing 0.7×
- Environmental Science 0.6×
- Mathematics 0.2×
- Decision Sciences 0.1×
- Psychology 0.1×
- Computer Science 0.0×
- Engineering 0.0×
Which keywords describe research at Cibles et Médicaments des Infections et de l'Immunité?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Antifungal Therapy, Immunocompromised Patients, Biofilm Formation, Candidiasis, Invasive Fungal Infections, Fungal Pathogens and Synthesis.
- Molecular Docking
- Pneumocystis
- Heterocycles
- Bioactivity
- HIV
- Pharmacology
- Endophytic Fungi
- Medicinal Plants
- Natural Products
- Cancer
- Antioxidant Activity
- Biological Evaluation
- Heterocyclic Compounds
- Anticancer Agents
- Histoplasmosis
- Virulence Factors
- Synthesis
- Invasive Fungal Infections
- Biofilm Formation
- Antifungal Therapy
- Epidemiology
- Immunocompromised Patients
- Candidiasis
- Fungal Pathogens
- Diagnosis
- Cryptococcal Disease
- Treatment
- Antimicrobial Activity
- Medicinal Chemistry
- Drug Resistance
- Cancer Therapy
- Anticancer
- Antiretroviral Therapy
- Drug Discovery
- Phylogenetic Analysis
- Coumarins
- Pneumonia
- Catalyst
- Opportunistic Infections
- Biological Activities
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology18▲ 6.5×37 topics
- Antifungal Therapy14▲ 208×3 topics
- Immunocompromised Patients10▲ 227×2 topics
- Biofilm Formation9▲ 171×2 topics
- Candidiasis9▲ 266×1 topic
- Invasive Fungal Infections9▲ 331×1 topic
- Fungal Pathogens6▲ 53×5 topics
- Synthesis5▲ 14×14 topics
- Diagnosis5▲ 7.3×14 topics
- Virulence Factors4▲ 35×6 topics
- Cryptococcal Disease4▲ 203×1 topic
- Histoplasmosis4▲ 203×1 topic
- Treatment4▲ 4.7×12 topics
- Anticancer Agents4▲ 23×8 topics
- Antimicrobial Activity4▲ 30×5 topics
- Heterocyclic Compounds4▲ 35×3 topics
- Medicinal Chemistry4▲ 14×7 topics
- Biological Evaluation4▲ 42×5 topics
- Drug Resistance3▲ 16×6 topics
- Antioxidant Activity3▲ 8.4×7 topics
- Cancer Therapy3▲ 7.1×9 topics
- Cancer3▲ 3.0×14 topics
- Anticancer3▲ 20×7 topics
- Natural Products3▲ 22×5 topics
- Antiretroviral Therapy2▲ 16×5 topics
- Medicinal Plants2▲ 9.6×7 topics
- Drug Discovery2▲ 8.5×8 topics
- Endophytic Fungi2▲ 30×2 topics
- Phylogenetic Analysis2▲ 8.0×4 topics
- Pharmacology2▲ 8.8×9 topics
- Coumarins2▲ 46×2 topics
- HIV2▲ 22×3 topics
- Pneumonia2▲ 40×2 topics
- Bioactivity2▲ 77×3 topics
- Catalyst2▲ 23×2 topics
- Heterocycles2▲ 14×5 topics
- Opportunistic Infections2▲ 66×1 topic
- Pneumocystis2▲ 88×1 topic
- Biological Activities2▲ 12×5 topics
- Molecular Docking2▲ 17×4 topics
Which research topics does Cibles et Médicaments des Infections et de l'Immunité publish most on?
By volume in 2022–2025: Antifungal resistance and susceptibility, Fungal Infections and Studies, Health, Medicine and Society and Plant Pathogens and Fungal Diseases.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Antifungal resistance and susceptibility Infectious Diseases 1 works
- 2 Fungal Infections and Studies Epidemiology 1 works
- 3 Health, Medicine and Society General Health Professions 0 works
- 4 Plant Pathogens and Fungal Diseases Cell Biology 0 works
- 5 Essential Oils and Antimicrobial Activity Food Science 0 works
- 6 CRISPR and Genetic Engineering Molecular Biology 0 works
- 7 Antibiotic Use and Resistance Applied Microbiology and Biotechnology 0 works
- 8 Cardiac Arrest and Resuscitation Emergency Medicine 0 works
- 9 Phytochemicals and Antioxidant Activities Biochemistry 0 works
- 10 Vibrio bacteria research studies Endocrinology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Cibles et Médicaments des Infections et de l'Immunité's research output changed?
Output in 2018–2022 was 23% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Nantes
- Institut de recherche en droit privé
- Laboratoire d'Economie et de Management de Nantes Atlantique
- Centre de recherches en histoire internationale et atlantique
- Laboratoire de Linguistique de Nantes
- Centre de Recherche sur les Identités, les Nations et l'Interculturalité
- methodS in Patient-centered outcomes and HEalth ResEarch
- Center for Research in Transplantation and Translational Immunology
- Unité en Sciences Biologiques et Biotechnologies de Nantes
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.